J. Ro

439 total citations
12 papers, 368 citations indexed

About

J. Ro is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Ro has authored 12 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Ro's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). J. Ro is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). J. Ro collaborates with scholars based in United States, South Korea and United Kingdom. J. Ro's co-authors include S. E. Vartivarian, Hagop Kantarjian, K. V. I. Rolston, E. Anaissie, Jennifer Hoy, Gerald P. Bodey, Roy L. Hopfer, Garth L. Nicolson, H Sawada and Sei‐Hyun Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Journal of Vascular and Interventional Radiology.

In The Last Decade

J. Ro

11 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Ro United States 5 169 146 127 99 48 12 368
K. Williams Canada 7 197 1.2× 183 1.3× 102 0.8× 101 1.0× 40 0.8× 11 440
Michael Locketz South Africa 10 340 2.0× 282 1.9× 172 1.4× 140 1.4× 58 1.2× 19 677
Andreas Petzer Austria 10 359 2.1× 306 2.1× 102 0.8× 106 1.1× 52 1.1× 11 585
Asli Bahadirli-Talbott United States 11 50 0.3× 100 0.7× 173 1.4× 98 1.0× 52 1.1× 12 533
Rodney P. Swartz United States 8 95 0.6× 102 0.7× 96 0.8× 35 0.4× 25 0.5× 11 350
Madalina Uzunov France 15 263 1.6× 230 1.6× 178 1.4× 127 1.3× 59 1.2× 34 717
Heinrich Lellek Germany 15 135 0.8× 165 1.1× 249 2.0× 105 1.1× 13 0.3× 21 637
Cornelis J. Korbee Netherlands 6 175 1.0× 177 1.2× 124 1.0× 59 0.6× 12 0.3× 6 391
Jyoti Asundi United States 9 45 0.3× 162 1.1× 165 1.3× 81 0.8× 27 0.6× 11 426
Henri Guy France 9 553 3.3× 490 3.4× 75 0.6× 201 2.0× 76 1.6× 11 765

Countries citing papers authored by J. Ro

Since Specialization
Citations

This map shows the geographic impact of J. Ro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ro more than expected).

Fields of papers citing papers by J. Ro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ro. The network helps show where J. Ro may publish in the future.

Co-authorship network of co-authors of J. Ro

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ro. A scholar is included among the top collaborators of J. Ro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ro. J. Ro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kang, Han‐Sung, et al.. (2011). A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2-positive early breast cancer.. Journal of Clinical Oncology. 29(15_suppl). e11069–e11069. 1 indexed citations
2.
Yoon, Chang Jin, Ho-Young Song, Jin Hyoung Kim, et al.. (2010). Temporary Placement of a Covered, Retrievable, Barbed Stent for the Treatment of Hormone-induced Benign Prostatic Hyperplasia: Technical Feasibility and Histologic Changes in Canine Prostates. Journal of Vascular and Interventional Radiology. 21(9). 1429–1435. 10 indexed citations
3.
Ro, J., Seung‐Kwon Myung, Dominique Berton-Rigaud, et al.. (2010). 48 The addition of capecitabine to neoadjuvant chemotherapy for early breast cancer (EBC): a review of clinical study data. European Journal of Cancer Supplements. 8(3). 72–72.
4.
Ro, J., et al.. (2006). ISUP/WHO Classification of Papillary Urothelial Neoplasms of Urinary Bladder: Consensus Study Conducted by Korean Society of Urogenital Pathology. The Korean Journal of Pathology. 282–288. 1 indexed citations
6.
Ahn, Sei‐Hyun, H Sawada, J. Ro, & Garth L. Nicolson. (1997). Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clinical & Experimental Metastasis. 15(2). 151–156. 97 indexed citations
7.
Iversen, John R., et al.. (1992). [Late diagnosis of advanced breast cancer--a challenge for health services].. PubMed. 112(14). 1821–4. 1 indexed citations
8.
Hortobágyi, Gabriel N., Richard L. Theriault, D. Frye, et al.. (1990). Pirarubicin in Combination Chemotherapy for Metastatic Breast Cancer. American Journal of Clinical Oncology. 13. S54–S54. 4 indexed citations
9.
Anaissie, E., Gerald P. Bodey, Hagop Kantarjian, et al.. (1989). New Spectrum of Fungal Infections in Patients with Cancer. Clinical Infectious Diseases. 11(3). 369–378. 214 indexed citations
10.
Ro, J., et al.. (1989). SIS/PDGF-B expression in benign and malignant human breast lesions.. PubMed. 4(3). 351–4. 18 indexed citations
11.
Ro, J., Giuseppe Fraschini, D. Frye, Aman U. Buzdar, & Gabriel N. Hortobágyi. (1989). Reutilization of doxorubicin in patients with progressive metastatic breast cancer. 2(4). 234–238. 3 indexed citations
12.
Ro, J., et al.. (1988). Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene.. PubMed. 48(14). 4045–8. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026